Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04435951
Other study ID # Hacettepe FTR
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 6, 2017
Est. completion date May 25, 2020

Study information

Verified date June 2020
Source Hacettepe University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study was to investigate the effects of temporomandibular joint dysfunction (TMJD) on pain, quality of life and psychological status.

A total of one hundred twenty people participated in the study, sixty with TMJD symptoms (according to the Research Diagnostic Criteria for Temporomandibular Disorders) and sixty without TMJD symptoms. The severity of temporomandibular joint (TMJ) pain and headache was assessed using a visual analog scale (VAS), pain threshold using an algometer, anxiety and depression levels with the Hospital Anxiety and Depression Scale (HADS), and the quality of life level was assessed by Short Form-36 (SF-36).

Treatment of TMJD with appropriate therapies and psychological support techniques may reduce TMJD symptoms and improve patients' quality of life and psychological status.


Description:

Temporomandibular joint dysfunction (TMJD) occurs as a result of the impaired functioning of the structures of the masticatory system. This disruption affects the chewing muscles, temporomandibular joint (TMJ), and related structures around the joint. TMJD can produce signs and symptoms, including pain in the TMJ and chewing muscles, restricted mouth opening, and articular sounds such as clicking and/or crepitus. Other symptoms include TMJ pain, limitation in joint movements, difficulty in chewing, jaw locking (trismus), lateral deviation of the jaw, tenderness in the TMJ and chewing muscles, tinnitus and pain, dizziness, and head and neck pain.

However, to the best of the investigator's knowledge, no previous studies have examined the relationship between quality of life, pain, and psychological status in individuals with TMJD. This study was designed to investigate whether a relationship between pain, quality of life, and psychological status in individuals with TMJD and asymptomatic individuals without TMJD.

One hundred twenty individuals were included in this study performed between March and July 2017 at the Gazi University and Ankara Yıldırım Beyazıt University Dentistry Faculties, Turkey. The research was designed as a controlled, observational, cross-sectional study. Sixty of the 165 individuals presenting with TMJD symptoms were diagnosed with TMJD by a specialist dentist, and those meeting the inclusion criteria were enrolled in the first group. Sixty individuals who met the inclusion criteria out of 143 individuals who did not exhibit TMJD symptoms were enrolled in the second group. These two groups were established based on clinical and radiological examination results. TMJD was diagnosed by professional and experienced dentists using the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD). RDC/TMD has been described as the gold standard physical examination method in the clinical diagnosis of TMD.

Individuals agreeing to take part in the study were included after signing informed consent forms. Ethical committee permission was granted by the Ankara Yıldırım Beyazıt University Social and Humanities Ethics Committee (date: 02.08.2016, no: 356).

Individuals who were able to understand and speak Turkish and cooperate, and aged 17 years or older were included in the study.

Inclusion criteria for Group 1 were articular sounds in the form of clicks or crepitation from the TMJ during mouth opening or chewing, sensitivity and pain in the TMJ at palpation, no treatment for the TMJ in the previous six months, and presence of TMJD symptoms for at least three months. Inclusion criteria for Group 2, maximum mouth opening exceeding 30 mm, absence of articular sounds such as TMJ click or crepitation during mouth opening and closing and/or chewing activity, and absence of tenderness and pain in the TMJ and chewing muscles at palpation.

Exclusion criteria for Group 1 were the absence of at least one of the TMJD symptoms, absence of diagnosis of TMJD and the presence of a history of tumor, cervical discopathy, orthopedic and rheumatic pathologies, head, neck and/or jaw surgery and pregnancy.

Exclusion criteria for Group 2 were the presence of at least one of the symptoms of TMJD, the presence of a history of tumor, cervical discopathy, orthopedic and rheumatic pathologies, head, neck and/or jaw surgery, and pregnancy.

G * Power (V.3.1.9.2, Germany) software was used to calculate the sample size. Analyses were performed to investigate significant differences in the pressure pain threshold (PTT), quality of life, and psychological evaluation results between the groups (α = 0.05 and β = 0.20). The analysis showed that at least 19 individuals in each group and at least 38 individuals in total would be sufficient.

Socio-demographic (age, sex, height, weight, educational status) and clinical data (history of bruxism, dominant side, side of the problem, duration of symptoms, dominant chewing side, sleeping position, tinnitus/pain, chewing difficulty, and parafunctional oral habits status) of individuals meeting the inclusion criteria were recorded onto an evaluation form.

Individuals in both groups were asked to mark TMJ pain and headache on a 10 cm straight line using a visual analog scale (VAS), and the results were recorded in cm. Patients were asked about pain in bilateral resting and mobile positions of the TMJ. On the VAS scale, "0" indicates no pain, and "10" the most severe pain possible.

Muscle sensitivity was measured using an algometer (Baseline® dolorimeter/algometer, Pain Diagnosis, and Treatment Inc., Great Neck, NY, USA). The algometer is pressed gradually to the area where the sensitivity is to be measured, and the measurement is terminated as soon as the subject experiences pain. The PPTs of the anterior part of the temporalis muscle, the TMJ lateral capsule, and the masseter muscle were measured in the present study. Measurements were performed three times at 30-second intervals on both right and left sides. The mean values of the three measurements were recorded. PPT is defined as the lowest pressure force required to be applied to the tissue for the pain to occur. Results are expressed as kg/cm2.

The Hospital Anxiety and Depression Scale (HADS) was used to measure participants' anxiety and depression levels. The HADS scale was developed by Zigmond and Snaith and contains 14, with two sub-scales, one of seven questions (odd numbers) measuring anxiety, and another of seven questions (even numbers) measuring depression. Aydemir et al. conducted the Turkish validity and reliability study of HADS. Each question is scored between 0 and 3. The lowest possible scores for the depression and anxiety subscales were 0, and the maximum possible scores were 21. Subjects' depression and anxiety status are evaluated as normal/no symptoms (0-7 points), borderline abnormal/suspicious (8-10 points), and abnormal/definite (11-21 points), depending on the scores obtained.

Short Form-36 (SF-36) was used to assess the quality of life. Ware et al. developed the SF-36 in 1987 to determine overall health-related life quality. The scale consists of 36 questions and evaluates life quality in the previous four weeks in eight subscales and two main components. The subscales are; Physical Function (PF), Role Difficulty-Physical (RP), Body Pain (BP), General Health (GH), Vitality (V), Social Function (SF), Role Difficulty-Emotional (RE), and Mental Health (MH), while the main components are Physical Component Score (PCS) and Mental Component Score (MCS). The eight subscales assess health from 0 to 100 points. "0" indicates that health-related quality of life is poor, and 100 indicates the best possible quality of life, so higher scores indicate better quality of life. SF-36 was translated into Turkish by Koçyiğit et al. and has been subjected to validity and reliability studies.

The distributions of continuous variables such as age, body mass index (BMI), and SF-36 scores were examined using the Shapiro-Wilk test and normality graphs. Mean ± standard deviation (mean ± sd) and median (min-max: minimum-maximum) were used to express all continuous variables, while results for categorical variables such as gender and occupation were expressed as percentages (%). The independent samples t-test and Mann-Whitney U test were applied to determine the distribution of continuous variables such as SF-36 and HADS scores between groups 1 and 2. The relationship between the scale scores and pain threshold and pain severity was analyzed using Pearson and Spearman correlation analysis. The consistency of responses to SF-36 and HADS was examined using Cronbach's alpha coefficient. Statistical significance was set at p <0.05. All statistical analyses and calculations were performed on IBM SPSS Statistics 21.0 software (IBM Corp. Released 2012. IBM SPSS Statistics for Windows, Armonk, NY: IBM Corp., USA).


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date May 25, 2020
Est. primary completion date July 24, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 17 Years to 57 Years
Eligibility Inclusion Criteria:

For Group 1 (group with TMJD):

- Patients diagnosed with TMJD

- Able to understand and speak Turkish and cooperate

- Aged 17 years or older and 65 years or younger

- Patients have articular sounds in the form of clicks or crepitation from the TMJ during mouth opening or chewing

- Sensitivity and pain in the TMJ at palpation

- Not receiving TMJ treatment in the past six months

- Presence of TMJD symptoms for at least three months For Group 2 (group without TMJD)

- Able to understand and speak Turkish and cooperate

- Aged 17 years or aged 17 years or older and 65 years or younger

- Maximum mouth opening 30 mm or more

- Absence of articular sounds such as TMJ click or crepitation during mouth opening and closing and/or chewing activity.

- Absence of tenderness and pain in the TMJ and chewing muscles at palpation

Exclusion Criteria:

For Group 1 (group with TMJD):

- Absence of at least one of the TMJD symptoms

- Presence of a history of tumor, cervical discopathy, orthopedic and rheumatic pathologies, head, neck and/or jaw surgery and pregnancy For Group 2 (group without TMJD)

- Presence of at least one of the symptoms of TMJD

- Presence of a history of tumor, cervical discopathy, orthopedic and rheumatic pathologies, head, neck and/or jaw surgery and pregnancy

Study Design


Related Conditions & MeSH terms

  • Joint Diseases
  • Temporomandibular Joint Disorders
  • Temporomandibular Joint Dysfunction
  • Temporomandibular Joint Dysfunction Syndrome

Intervention

Other:
Evaluation
No attempt was made to the individuals in Group 1 and Group 2. Individuals were only evaluated.

Locations

Country Name City State
Turkey Ankara Yildirim Beyazit University Faculty of Health Sciences Department of Physiotherapy and Rehabilitation Ankara

Sponsors (1)

Lead Sponsor Collaborator
Hacettepe University

Country where clinical trial is conducted

Turkey, 

References & Publications (42)

Almoznino G, Zini A, Zakuto A, Sharav Y, Haviv Y, Hadad A, Chweidan H, Yarom N, Benoliel R. Oral Health-Related Quality of Life in Patients with Temporomandibular Disorders. J Oral Facial Pain Headache. 2015 Summer;29(3):231-41. doi: 10.11607/ofph.1413. E — View Citation

Aydemir, Ö, Guvenir, T, Kuey, L, & Kultur, S. Validity and reliability of Turkish version of hospital anxiety and depression scale. Turk Psikiyatri Derg. 1997; 8(4); 280-287.

Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K. Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med. 2008 Oct;70(8):890-7. doi: 10.1097/PSY.0b013e318185c510. Epub 200 — View Citation

Barbosa Tde S, Miyakoda LS, Pocztaruk Rde L, Rocha CP, Gavião MB. Temporomandibular disorders and bruxism in childhood and adolescence: review of the literature. Int J Pediatr Otorhinolaryngol. 2008 Mar;72(3):299-314. doi: 10.1016/j.ijporl.2007.11.006. Ep — View Citation

Barros Vde M, Seraidarian PI, Côrtes MI, de Paula LV. The impact of orofacial pain on the quality of life of patients with temporomandibular disorder. J Orofac Pain. 2009 Winter;23(1):28-37. — View Citation

Chesterton LS, Sim J, Wright CC, Foster NE. Interrater reliability of algometry in measuring pressure pain thresholds in healthy humans, using multiple raters. Clin J Pain. 2007 Nov-Dec;23(9):760-6. — View Citation

Chisnoiu AM, Picos AM, Popa S, Chisnoiu PD, Lascu L, Picos A, Chisnoiu R. Factors involved in the etiology of temporomandibular disorders - a literature review. Clujul Med. 2015;88(4):473-8. doi: 10.15386/cjmed-485. Epub 2015 Nov 15. Review. — View Citation

Daher, CRDM., Cunha, LFD., Ferreira, APDL., Souza, AISDO., Rêgo, TAM., Araújo, M. DGRD., & Silva, HJD. Pain threshold, sleep quality and anxiety levels in individuals with temporomandibular disorders. Revista CEFAC. 2018; 20(4); 450-458.

Dahlström L, Carlsson GE. Temporomandibular disorders and oral health-related quality of life. A systematic review. Acta Odontol Scand. 2010 Mar;68(2):80-5. doi: 10.3109/00016350903431118. Review. — View Citation

Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord. 1992 Fall;6(4):301-55. Review. — View Citation

Gameiro GH, da Silva Andrade A, Nouer DF, Ferraz de Arruda Veiga MC. How may stressful experiences contribute to the development of temporomandibular disorders? Clin Oral Investig. 2006 Dec;10(4):261-8. Epub 2006 Aug 22. Review. — View Citation

Gungormus Z, Erciyas K. Evaluation of the relationship between anxiety and depression and bruxism. J Int Med Res. 2009 Mar-Apr;37(2):547-50. — View Citation

Kampe T, Edman G, Bader G, Tagdae T, Karlsson S. Personality traits in a group of subjects with long-standing bruxing behaviour. J Oral Rehabil. 1997 Aug;24(8):588-93. — View Citation

Kocyigit H. Reliability and validity of the Turkish version of short form-36 (SF-36): a study in a group of patients will rheumatic diseases. Turk J Drugs Ther. 1999; 12; 102-106.

Krogstad BS, Jokstad A, Dahl BL, Vassend O. Relationships between risk factors and treatment outcome in a group of patients with temporomandibular disorders. J Orofac Pain. 1996 Winter;10(1):48-53. — View Citation

Lee LT, Yeung RW, Wong MC, McMillan AS. Diagnostic sub-types, psychological distress and psychosocial dysfunction in southern Chinese people with temporomandibular disorders. J Oral Rehabil. 2008 Mar;35(3):184-90. doi: 10.1111/j.1365-2842.2007.01792.x. — View Citation

Manfredini D, Landi N, Fantoni F, Segù M, Bosco M. Anxiety symptoms in clinically diagnosed bruxers. J Oral Rehabil. 2005 Aug;32(8):584-8. — View Citation

Manfredini D, Landi N, Romagnoli M, Bosco M. Psychic and occlusal factors in bruxers. Aust Dent J. 2004 Jun;49(2):84-9. — View Citation

Manfredini D, Winocur E, Guarda-Nardini L, Paesani D, Lobbezoo F. Epidemiology of bruxism in adults: a systematic review of the literature. J Orofac Pain. 2013 Spring;27(2):99-110. doi: 10.11607/jop.921. Review. — View Citation

Melis M, Abou-Atme YS. Prevalence of bruxism awareness in a Sardinian population. Cranio. 2003 Apr;21(2):144-51. — View Citation

Moss RA, Adams HE. Physiological reactions to stress in subjects with and without myofascial pain dysfunction symptoms. J Oral Rehabil. 1984 May;11(3):219-32. — View Citation

Ohrbach R, Dworkin SF. Five-year outcomes in TMD: relationship of changes in pain to changes in physical and psychological variables. Pain. 1998 Feb;74(2-3):315-26. — View Citation

Oliveira LK, Almeida Gde A, Lelis ÉR, Tavares M, Fernandes Neto AJ. Temporomandibular disorder and anxiety, quality of sleep, and quality of life in nursing professionals. Braz Oral Res. 2015;29. pii: S1806-83242015000100265. doi: 10.1590/1807-3107BOR-201 — View Citation

Pond LH, Barghi N, Barnwell GM. Occlusion and chewing side preference. J Prosthet Dent. 1986 Apr;55(4):498-500. — View Citation

Rener-Sitar K, Celebic A, Stipetic J, Marion L, Petricevic N, Zaletel-Kragelj L. Oral health related quality of life in Slovenian patients with craniomandibular disorders. Coll Antropol. 2008 Jun;32(2):513-7. — View Citation

Resende CM, Alves AC, Coelho LT, Alchieri JC, Roncalli AG, Barbosa GA. Quality of life and general health in patients with temporomandibular disorders. Braz Oral Res. 2013 Mar-Apr;27(2):116-21. Epub 2013 Mar 1. — View Citation

Rocha CO, Peixoto RF, Resende CM, Alves AC, Oliveira ÂG, Barbosa GA. Psychosocial aspects and temporomandibular disorders in dental students. Quintessence Int. 2017;48(3):241-249. doi: 10.3290/j.qi.a37128. — View Citation

Santana-Mora U, López-Cedrún J, Mora MJ, Otero XL, Santana-Penín U. Temporomandibular disorders: the habitual chewing side syndrome. PLoS One. 2013 Apr 8;8(4):e59980. doi: 10.1371/journal.pone.0059980. Print 2013. — View Citation

Schierz O, John MT, Reissmann DR, Mehrstedt M, Szentpétery A. Comparison of perceived oral health in patients with temporomandibular disorders and dental anxiety using oral health-related quality of life profiles. Qual Life Res. 2008 Aug;17(6):857-66. doi — View Citation

Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, List T, Svensson P, Gonzalez Y, Lobbezoo F, Michelotti A, Brooks SL, Ceusters W, Drangsholt M, Ettlin D, Gaul C, Goldberg LJ, Haythornthwaite JA, Hollender L, Jensen R, John MT, De Laat A, — View Citation

Silva AA Jr, Brandão KV, Faleiros BE, Tavares RM, Lara RP, Januzzi E, Carvalho AB, Carvalho EM, Gomes JB, Leite FM, Alves BM, Gómez RS, Teixeira AL. Temporo-mandibular disorders are an important comorbidity of migraine and may be clinically difficult to d — View Citation

Storm C, Wänman A. Temporomandibular disorders, headaches, and cervical pain among females in a Sami population. Acta Odontol Scand. 2006 Oct;64(5):319-25. — View Citation

Suvinen TI, Hanes KR, Gerschman JA, Reade PC. Psychophysical subtypes of temporomandibular disorders. J Orofac Pain. 1997 Summer;11(3):200-5. — View Citation

Suvinen TI, Reade PC, Kemppainen P, Könönen M, Dworkin SF. Review of aetiological concepts of temporomandibular pain disorders: towards a biopsychosocial model for integration of physical disorder factors with psychological and psychosocial illness impact — View Citation

Vanderas AP, Menenakou M, Papagiannoulis L. Emotional stress and craniomandibular dysfunction in children. Cranio. 2001 Apr;19(2):123-9. — View Citation

Vedolin GM, Lobato VV, Conti PC, Lauris JR. The impact of stress and anxiety on the pressure pain threshold of myofascial pain patients. J Oral Rehabil. 2009 May;36(5):313-21. doi: 10.1111/j.1365-2842.2008.01932.x. Epub 2009 Feb 6. — View Citation

Visscher CM, Lobbezoo F, Naeije M. Comparison of algometry and palpation in the recognition of temporomandibular disorder pain complaints. J Orofac Pain. 2004 Summer;18(3):214-9. — View Citation

Wänman A. The relationship between muscle tenderness and craniomandibular disorders: a study of 35-year-olds from the general population. J Orofac Pain. 1995 Summer;9(3):235-43. — View Citation

Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83. — View Citation

Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health. 1990 Aug;13(4):227-36. Review. — View Citation

Wright AR, Gatchel RJ, Wildenstein L, Riggs R, Buschang P, Ellis E 3rd. Biopsychosocial differences between high-risk and low-risk patients with acute TMD-related pain. J Am Dent Assoc. 2004 Apr;135(4):474-83. — View Citation

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. — View Citation

* Note: There are 42 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Temporomandibular joint pain severity and headache severity Individuals in both groups were asked to mark TMJ pain and headache on a 10 cm straight line using a visual analogue scale (VAS), and the results were recorded in cm. Patients were asked about pain in bilateral resting and mobile positions of the TMJ. On the VAS scale, "0" indicates no pain, and "10" the most severe pain possible. 5 months
Secondary Psychological status (anxiety and depression levels) The Hospital Anxiety and Depression Scale (HADS) was used to measure participants' anxiety and depression levels. Each question was scored between 0 and 3. The lowest possible scores for the depression and anxiety subscales were 0, and the maximum possible scores were 21. Subjects' depression and anxiety status was evaluated as normal/no symptoms (0-7 points), borderline abnormal/suspicious (8-10 points) and abnormal/definite (11-21 points), depending on the scores obtained. 5 months
Secondary Short Form-36 Short Form-36 (SF-36) was used to assess health-related quality of life. The scale consists of 36 questions and evaluates life quality in the previous four weeks in eight subscales and two main components. The eight subscales assess health from 0 to 100 points. "0" indicates that health-related quality of life is poor, and 100 indicates the best possible quality of life, so higher scores indicate better quality of life. 5 months
See also
  Status Clinical Trial Phase
Completed NCT01958879 - Efficacy of Arthrocentesis by Injection of Ringer With or Without Corticosteroid in Treatment of Internal Derangement Phase 2
Completed NCT05381129 - The Effect of Accompanying Temporomandibular Joint Dysfunction in Patients With Chronic Migraine N/A
Not yet recruiting NCT06328998 - Intra-articular Injection Versus Normal Rehabilitation Therapy on Temporomandibular Joint Dysfunction N/A
Not yet recruiting NCT06301620 - Intra-articular Injection: A Innovational Approach for Joint Disorder N/A
Not yet recruiting NCT02294799 - Magnetic Ressonance Imaging of Temporomandibular Joint N/A
Completed NCT05420896 - Electromyographic Evaluation of the Efficacy of Manual Therapy in Temporomandibular Joint Dysfunction. N/A
Completed NCT04122352 - The Effects of Trigger Point Treatment in Temporomandibular Joint Dysfunction N/A
Completed NCT02822469 - Thermograph Evaluation of Masticatory and Cervical Muscles After Physiotherapeutic Treatment in Tmd Subjects N/A
Completed NCT01524913 - A Double Blind Study Comparing Hyaluronic Acid, Corticosteroid and Placebo During Arthrocentesis for TMJ Phase 4
Completed NCT00636727 - A Comparison of Arthrocentesis, Arthroscopy and Arthroplasty in the Treatment of Temporomandibular Joint Dysfunction N/A
Withdrawn NCT06213675 - Effect of Intra-articular Injection on Temporomandibular Joint Dysfunction N/A
Completed NCT05422703 - Manual Therapy and Kinesio Taping on Temporomandibular Joint Dysfunction Following Oral Surgeries N/A
Recruiting NCT06186817 - Effectiveness of the Fascial Distortion Model on the Cervical Spine in Individuals With Temporomandibular Disorder N/A
Completed NCT03287531 - Effect of Conventional Therapy and Low Level Laser Therapy on Pain and Function in Patients With Temporomandibular Joint Dysfunction N/A
Completed NCT06228690 - Comparison of Gold Fish Exercises and Cervico-thoracic Postural Correction Training in Patients With TMJD N/A